LegalView Reports on Potential Link Between Children with TBI and the Development of ADHD

LegalView recently informed traumatic brain injury (TBI) blog readers of a medical link found between children who have suffered from TBI and an increased risk of developing attention deficit hyperactivity disorder (ADHD). According to the British Medical Journal, TBI may also be the result of children's "risk-taking characteristics" associated with an ADHD diagnosis.

Denver, CO, November 14, 2008 --(PR.com)-- LegalView, the most comprehensive legal resource available on the Internet, recently informed traumatic brain injury (TBI) blog readers of a link between children who have sustained a TBI with an increased risk of developing attention deficit hyperactivity disorder (ADHD). According to an article published in a recent edition of the British Medical Journal (BMJ), children who suffered from TBI had a 90 percent increased risk of developing ADHD before the ages of 10. Additionally, researchers believe that if TBI is not the cause of ADHD among TBI child victims, then an ADHD diagnosis is likely the cause of TBI due to "risk-taking characteristic" associated with ADHD.

TBI is one of the most common injuries in America and around the world. There are currently 5.4 million individuals living with TBI in the United States. Many of these victims go untreated for their TBI symptoms, which can often lead to a worsened condition. TBI victims are suggested to discuss their condition with a medical professional as well as an experienced personal injury law firm that can provide contact with a brain injury lawyer. It may be possible to develop a brain injury lawsuit, which could lead to the potential for receiving monetary compensation for damages incurred.

In addition to LegalView's comprehensive traumatic brain injury information portal, LegalView also offers a plethora of additional information portals on topics ranging from mesothelioma cancer and the development of Nephrogenic Systemic Fibrosis (NSF) to providing information on controversial pharmaceuticals such as Ketek.

Mesothelioma cancer is considered a rare condition because it affects a portion of the population that has been exposed to asbestos fibers and dust, which causes the development of cancerous cells on the lining of the lung. However, this cancer is unique in that most individuals who have developed the condition are unaware of their cancer until symptoms appeared years and even decades later. Mesothelioma cancer remains dormant for years and is often dubbed a silent killer. Individuals who have developed mesothelioma may be able to seek legal counsel for their condition and should consider contacting an experienced mesothelioma attorney.

Nephrogenic Systemic Fibrosis (NSF) is also considered an uncommon condition and while its cause has yet to be determined, there has been a strong link between kidney patients receiving gadolinium dyes during magnetic resonance imaging/magnetic resonance angiogram (MRI/MRA) testing and the development of the condition. To learn more about this rare and extremely debilitating condition, which often causes the skin to thicken and swell to the point that joints cannot be bent, it is important for an NSF patient to not only seek medical counsel but to also locate an NSF lawyer as well. Often, medical bills are extremely expensive and developing a lawsuit may offer monetary reward as compensation for this preventable condition.

LegalView's pharmaceutical information portals are also a wealth of information for patients who have suffered from severe and unintended side effects linked to a prescription drug. Ketek, for example, was manufactured by Sanofi-Aventis and released in April 2004. Only a couple of years following the drug's release did patients of this upper respiratory antibiotic begin to report severe side effects found among patients with liver failure. Ketek has been linked to liver failure as well as several hospitalizations and deaths among patients. It is important for a patient of Ketek to discuss stopping the antibiotic with their medical professional as well as contacting a pharmaceutical attorney for involvement in a potential Ketek class action lawsuit, which could reward Ketek victims with monetary compensation.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

###
Contact
LegalView
Katie Kelley
720-771-3246
http://www.ketek-legal-help.com
ContactContact
Categories